The analysis of allele frequencies for the rs4645878 and rs13281615 polymorphisms also showed no relationship with the risk of ovarian cancer (for rs4645878 BAX G: 87.25% vs. 85.50, A: 12.75% vs. 14.50%; OR = 1.16; p = 0.062; for rs13281615 c-MYC A: 55.10% vs. 59.00%, G: 44.90% vs. 41.00%; OR = 0.76; p = 0.642). This evidence concerns the gene BAX and ovarian cancer.